Comment
doi: 10.1016/S1474-4422(22)00172-7.
Epub 2022 May 4.
Tenecteplase for acute stroke: the thrombolysis puzzle
Affiliations
- PMID: 35525249
- DOI: 10.1016/S1474-4422(22)00172-7
Item in Clipboard
Comment
Tenecteplase for acute stroke: the thrombolysis puzzle
Lancet Neurol.
2022 Jun.
No abstract available
Conflict of interest statement
SBC is the Principal investigator of the TEMPO-2 trial, for which Boehringer Ingelheim provides study drug (tenecteplase). AYXY declares funding support from the Heart & Stroke Foundation of Canada and the Canadian Institutes of Health Research.
Comment on
-
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.Lancet Neurol. 2022 Jun;21(6):511-519. doi: 10.1016/S1474-4422(22)00124-7. Epub 2022 May 4. Lancet Neurol. 2022. PMID: 35525250 Clinical Trial.
Similar articles
-
Re: Tenecteplase for thrombolysis in stroke patients: Systematic review with meta-analysis.Am J Emerg Med. 2022 May;55:185-186. doi: 10.1016/j.ajem.2021.05.079. Epub 2021 Jun 1. Am J Emerg Med. 2022. PMID: 34116894 Free PMC article. No abstract available.
-
Tenecteplase to Replace Alteplase? Comparing Thrombolytic Therapies for Acute Ischemic Stroke: June 2023 Annals of Emergency Medicine Journal Club.Ann Emerg Med. 2023 Jun;81(6):759-760. doi: 10.1016/j.annemergmed.2023.04.012. Ann Emerg Med. 2023. PMID: 37210165 No abstract available.
-
Should Tenecteplase Replace Alteplase for Acute Thrombolysis?Stroke. 2021 Mar;52(3):1091-1093. doi: 10.1161/STROKEAHA.120.033593. Epub 2021 Feb 16. Stroke. 2021. PMID: 33588587 No abstract available.
-
Acute Treatment of Ischemic Stroke.Neurol Clin. 2022 Feb;40(1):17-32. doi: 10.1016/j.ncl.2021.08.002. Neurol Clin. 2022. PMID: 34798968 Review.
-
Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials.Int J Stroke. 2018 Dec;13(9):885-892. doi: 10.1177/1747493018790024. Epub 2018 Jul 23. Int J Stroke. 2018. PMID: 30035698 Review.
Cited by
-
Tenecteplase vs. alteplase for the treatment of patients with acute ischemic stroke: a systematic review and meta-analysis.J Neurol. 2022 Oct;269(10):5262-5271. doi: 10.1007/s00415-022-11242-4. Epub 2022 Jul 1. J Neurol. 2022. PMID: 35776193
-
Developing a nomogram model for 3-month prognosis in patients who had an acute ischaemic stroke after intravenous thrombolysis: a multifactor logistic regression model approach.BMJ Open. 2024 Jul 24;14(7):e079428. doi: 10.1136/bmjopen-2023-079428. BMJ Open. 2024. PMID: 39053953 Free PMC article.
-
Switching to Tenecteplase from Alteplase for Ischemic Stroke: Is it the Time for Universal Adoption?Ann Neurosci. 2022 Oct;29(4):201-202. doi: 10.1177/09727531221125589. Epub 2022 Sep 15. Ann Neurosci. 2022. PMID: 37064286 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
